marginally significantP = 0.062
F4 disorders increased from 9.8% in Phase 1 to 21.6% in Phase 2, with a marginally significant P value (P = 0.062; Figure S4 ).
F4 disorders increased from 9.8% in Phase 1 to 21.6% in Phase 2, with a marginally significant P value (P = 0.062; Figure S4 ).